Most Viewed Sarcoma Current Events | Sarcoma News
|
|
|
Sort By:
Relevance | Date |
Sunitinib prolongs survival in GIST patients after imatinib mesylate failure
Updated results from a Phase III trial presented at the 13th European Cancer Conference (ECCO) show that sunitinib (SU11248) prolongs both progression-free and overall survival in patients with progressive metastatic and/or unresectable GIST whose disease has failed to respond to the standard therapy-imatinib mesylate. view more (2005-11-04)
Specific treatments for each type of sarcoma
The new molecular techniques allow designing specific treatments for a great number of sarcomas, according to Dr. Enrique de Alava, expert of the department of Pathologic Anatomy of the University Clinic of the University of Navarre. The molecular knowledge has become a very useful tool to study several diseases. In particular, it provides... view more... (2002-11-29)
New understanding of Ewing's sarcoma suggests novel treatment strategy
Using molecular and cell-based models, researchers at Georgetown University Medical Center have refined the picture of how a cancer-promoting protein associated with Ewing's sarcoma functions. view more (2006-06-01)
Blood transfusion-transmitted infections: A global perspective
Thanks to the many blood-safety interventions introduced since 1984, the overall risk for most transfusion-transmitted infections has become exceedingly small. view more (2006-09-28)
Landmark discovery of a Kaposi's sarcoma-associated herpesvirus receptor
Researchers at the National Institute of Allergy and Infectious Disease (NIAID), a component of the National Institutes of Health (NIH), have identified a critical human cell surface molecule involved in infection by Kaposi's sarcoma herpesvirus (KSHV), the virus that causes Kaposi's sarcoma and certain forms of lymphoma. view more (2006-04-07)
Childhood cancer survivors at increased risk of sarcoma
Survivors of childhood cancers have a ninefold increased risk of developing a secondary sarcoma—a cancer of connective or supportive tissue such as bone, fat, or muscle—compared with the general population. view more (2007-02-21)
Inhibition of iron-metabolizing enzyme reduces tumor growth
A report in the Journal of Biological Chemistry shows that inhibition of heme oxygenase-1, an enzyme involved in iron metabolism, reduces Kaposi sarcoma tumor growth. view more (2006-04-21)
UF scientists identify cancer virus' genetic targets
University of Florida researchers have identified specific human genes targeted by a virus believed to cause Kaposi's sarcoma, a rare form of cancer associated with AIDS and with organ transplants that causes patches of red or purple tissue to grow under people's skin. view more (2007-05-11)
Inducing Melanoma for Cancer Vaccine Development
Cancer vaccines are being investigated in early-phase clinical trials around the world, with many of those trials recruiting patients with melanoma. view more (2006-03-28)
Kidney transplantation linked with increased risk of various cancers
Following kidney transplantation, some recipients may face a 3-fold increased risk of certain cancer types, according to a study in the December 20 issue of JAMA. view more (2006-12-20)
First report that apoptotic and anti-angiogenic therapies work better together than alone
American researchers have found that giving a combination of imantanib (Glivec) and a drug that induces cell death (apoptosis) was better at inhibiting the growth of Ewing's sarcoma in mice than either therapy on its own. view more (2006-11-13)
An AIDS-related virus tricks cells to become tumors, new Penn study finds
Researchers at the University of Pennsylvania School of Medicine have discovered how the Kaposi's sarcoma-associated herpesvirus (KSHV) subverts a normal cell process in order to promote tumor growth. view more (2006-11-09)
Mice lacking key immune component still control chronic viral infections
Despite lack of a key component of the immune system, a line of genetically engineered mice can control chronic herpes virus infections, researchers at Washington University School of Medicine in St. Louis have found. view more (2006-05-30)
New way of tracking muscle damage from radiation
Magnetic resonance imaging (MRI) could become a valuable tool for predicting the risk of muscle injury during and following radiation therapy. view more (2006-11-07)
Life Threatening Gastrointestinal Tumour More Common Than Suspected
Swedish Data Show that GISTs Occur at Triple the Rate Previously Believed, Highlighting Importance of Effective New Therapy NICE, France, 20 October 2002 - The incidence of gastrointestinal stromal tumours (GISTs), generally considered a rare sarcoma, is more than three times as high as previously believed, according to data presented today at the... view more... (2002-10-21)
Finnish scientists discovered a new approach to treat virus-induced lymphomas
Kaposi's sarcoma herpesvirus (KSHV) is a human tumor virus and an etiological agent for Kaposi's sarcoma and primary effusion lymphoma (PEL). view more (2007-03-16)
Rate of secondary cancers increases over years after treatment for childhood leukemia
Survivors of acute lymphoblastic leukemia have a significantly increased risk of secondary cancers developing over 30 years after leukemia treatment when compared to the general population. view more (2007-03-21)
Marijuana component opens the door for virus that causes Kaposi's sarcoma
The major active component of marijuana could enhance the ability of the virus that causes Kaposi's sarcoma to infect cells and multiply. view more (2007-08-02)
Genetic analysis enables personalising of treatment of cancer of the lung and colon and of certain sarcomas
Genetic analysis has enabled the personalising of the pharmaceutical treatment of patients with cancer, enhancing thereby therapeutic efficacy and minimising possible toxicity. view more (2007-03-06)
Life Threatening Gastrointestinal Tumour More Common Than Suspected
The incidence of gastrointestinal stromal tumours (GISTs), generally considered a rare sarcoma, is more than three times as high as previously believed, according to data presented in Nice at the 27th annual European Society of Medical Oncology (ESMO) Congress. An accurate estimate of GIST incidence has been elusive because of diagnostic... view more... (2002-10-22)
|
|
|
|
Sort By:
Relevance | Date |
|
